Literature DB >> 29214571

Preparing Data at the Source to Foster Interoperability across Rare Disease Resources.

Marco Roos1, Estrella López Martin2, Mark D Wilkinson3.   

Abstract

The ability to combine heterogeneous data distributed across the globe is critically important to boost research on rare diseases, but it presents a number of methodological, representational and automation challenges. In this scenario, biomedical ontologies are of critical importance for enabling computers to aid in information retrieval and analysis across data collections.This chapter presents an approach to preparing rare disease data for integration through the application of a global standard for computer-readable data and knowledge. This includes the use of common data elements, ontological codes and computer-readable data. This approach was developed under a number of domain-relevant requirements, such as controlled access to data, independence of the original sources, and the desire to combining the data sources with other computational workflows and data platforms.

Entities:  

Keywords:  Data integration; FAIR approach; Linkable data; Ontologies; Semantic model; Standardization

Mesh:

Year:  2017        PMID: 29214571     DOI: 10.1007/978-3-319-67144-4_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

Review 1.  Knowledge-based approaches to drug discovery for rare diseases.

Authors:  Vinicius M Alves; Daniel Korn; Vera Pervitsky; Andrew Thieme; Stephen J Capuzzi; Nancy Baker; Rada Chirkova; Sean Ekins; Eugene N Muratov; Anthony Hickey; Alexander Tropsha
Journal:  Drug Discov Today       Date:  2021-10-27       Impact factor: 8.369

Review 2.  The case for open science: rare diseases.

Authors:  Yaffa R Rubinstein; Peter N Robinson; William A Gahl; Paul Avillach; Gareth Baynam; Helene Cederroth; Rebecca M Goodwin; Stephen C Groft; Mats G Hansson; Nomi L Harris; Vojtech Huser; Deborah Mascalzoni; Julie A McMurry; Matthew Might; Christoffer Nellaker; Barend Mons; Dina N Paltoo; Jonathan Pevsner; Manuel Posada; Alison P Rockett-Frase; Marco Roos; Tamar B Rubinstein; Domenica Taruscio; Esther van Enckevort; Melissa A Haendel
Journal:  JAMIA Open       Date:  2020-09-11

3.  A nomenclature and classification for the congenital myasthenic syndromes: preparing for FAIR data in the genomic era.

Authors:  Rachel Thompson; Angela Abicht; David Beeson; Andrew G Engel; Bruno Eymard; Emmanuel Maxime; Hanns Lochmüller
Journal:  Orphanet J Rare Dis       Date:  2018-11-26       Impact factor: 4.123

4.  Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome.

Authors:  Rachel Thompson; Gisèle Bonne; Paolo Missier; Hanns Lochmüller
Journal:  Emerg Top Life Sci       Date:  2019-01-28

5.  Community Approaches for Integrating Environmental Exposures into Human Models of Disease.

Authors:  Anne E Thessen; Cynthia J Grondin; Resham D Kulkarni; Susanne Brander; Lisa Truong; Nicole A Vasilevsky; Tiffany J Callahan; Lauren E Chan; Brian Westra; Mary Willis; Sarah E Rothenberg; Annie M Jarabek; Lyle Burgoon; Susan A Korrick; Melissa A Haendel
Journal:  Environ Health Perspect       Date:  2020-12-28       Impact factor: 9.031

Review 6.  Meeting Patients' Right to the Correct Diagnosis: Ongoing International Initiatives on Undiagnosed Rare Diseases and Ethical and Social Issues.

Authors:  Sabina Gainotti; Deborah Mascalzoni; Virginie Bros-Facer; Carlo Petrini; Giovanna Floridia; Marco Roos; Marco Salvatore; Domenica Taruscio
Journal:  Int J Environ Res Public Health       Date:  2018-09-21       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.